Anti-hnRNP-Q Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project
(www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry.
The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these
protocols and other useful information about Prestige Antibodies and the HPA, visit .
Allgemeine Beschreibung
Synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP) belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) family. This protein is located in the cytoplasm and is made up of three conserved RNA recognition motif (RRM) domains, an N-terminal domain, and a long, unstructured C-terminal domain. The SYNCRIP gene is located on the human chromosome at 6q14.3.
Biochem/physiol Actions
Synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP) functions as an RNA-binding protein and is involved in muscular and neuronal development in mammals and Drosophila. It plays a role in the RNA replication of mouse hepatitis virus (MHV) and hepatitis C virus (HCV). Dysregulation of the SYNCRIP gene leads to neurodegenerative disorders and severe cardiomyopathies.
Anti-hnRNP-Q Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
